Ergothioneine is a sulfur-containing amino acid found naturally in mushrooms, and it has drawn “healthy ageing” attention because of its role as an antioxidant inside cells. Brands abroad ask for a Japan-made ergothioneine product on the strength of that interest, often before checking what the human evidence actually covers.
This guide is for brand owners planning an ergothioneine product made in Japan. It covers what small human trials have shown so far, the ingredient’s EU novel food status, how ergothioneine is typically sourced, and what to fix before asking for a quotation.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning an ergothioneine product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Human evidence for ergothioneine is still early — a small pilot study confirmed it is absorbed from mushrooms, and a 12-week trial of an ergothioneine-rich mushroom extract reported improvements in skin moisture and texture.
| Study | Design | Reported result |
|---|---|---|
| Randomised, cross-over, dose-response pilot study, Preventive Medicine 2012;54(Suppl):S75-8 (PMID 22230474) | 10 healthy men; mushroom test meals providing 8 g or 16 g of mushroom powder, with postprandial blood sampling | Ergothioneine was bioavailable from mushrooms, with a trend toward a blunted post-meal triglyceride response at both doses |
| Randomised, double-blind, placebo-controlled trial, Frontiers in Medicine 2024;11:1396783 (PMID 38887673) | 77 women; an ergothioneine-rich mushroom extract or placebo daily for 12 weeks | Plasma ergothioneine rose about 4.7-fold in the supplemented group; skin moisture increased at 8 and 12 weeks, and wrinkle and texture scores were significantly better than placebo at 12 weeks |
Points to keep in view:
- Small studies. Ten and 77 participants respectively are small groups, and the 2012 study was a single-meal pilot, not a trial of ongoing daily supplementation.
- Different outcomes. The 2012 study measured absorption and an early metabolic trend; the 2024 study measured skin appearance after 12 weeks of daily use. Neither is evidence for a broader healthy-ageing or longevity outcome.
- More trials needed. Reviewers of ergothioneine research have generally described the human evidence base as early, with calls for larger and longer controlled trials.
Checked against the published abstracts on 25 September 2026.
What the EU novel food rules say
Synthetic L-ergothioneine has been authorised as a novel food in the EU for use in food supplements, at defined maximum daily amounts — that authorisation is about safety, not an approved health claim.
The European Food Safety Authority assessed the safety of synthetic L-ergothioneine as a novel food and issued a favourable opinion in 2016. Following that opinion, the European Commission authorised its use in food supplements for the general population, excluding infants, young children, and pregnant or breastfeeding women, later extending the authorisation; the permitted maximum intake is 30 mg a day for adults and 20 mg a day for children. No specific ergothioneine health claim has been authorised under the EU’s nutrition and health claims register.
Two lessons for a brand:
- Novel food status is about safety, not efficacy. It confirms the material is cleared for food supplement use at a defined specification and intake level, not that a health outcome has been proven.
- Naturally occurring ergothioneine in mushrooms is a different starting point from the synthetic novel food ingredient. Confirm which material and specification your supplier is offering, since the regulatory history above applies to the synthetic form assessed by EFSA.
💬 Need an evidence summary for your regulatory adviser that separates the trial evidence from the EU novel food authorisation? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe ergothioneine by what has actually been measured in small trials, not by antioxidant or longevity claims no human trial has tested.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains ergothioneine, with the amount per serving" | "Slows ageing”, “extends lifespan”, “anti-ageing” as a product promise |
| ”Studied in a 12-week trial for skin moisture and texture” | Citing skin results as evidence for unrelated outcomes such as cognition or disease risk |
| Naming the study you cite, with its size and duration | ”Clinically proven” without naming the study |
How ergothioneine is formulated
Ergothioneine is stable and water-soluble, and it is dosed in single-digit to low double-digit milligrams, which keeps most dosage forms open.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Hard capsule | Simple, low-dose format | Easy to combine with other healthy-ageing ingredients |
| Tablet | Low cost per serving | Excipient choice for the target market |
| Powder stick or sachet | Flexible dosing, mixes into drinks | Taste and moisture protection |
Decisions that shape the specification:
- Source. Ergothioneine used in supplements can be naturally sourced from mushrooms or produced synthetically; ask the supplier for the production method, purity and certificate of analysis, since the regulatory history for the synthetic form differs from a mushroom-derived extract.
- Amount per serving. Match the amount to a study you intend to cite, and confirm it sits within any maximum daily intake set for your target market, such as the EU’s 30 mg/day limit for adults.
- Companion ingredients. Ergothioneine is often combined with other antioxidant or healthy-ageing ingredients. Each companion needs its own check against Japanese food law and your target market’s rules.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Mushrooms themselves are common foods in Japan. Companion ingredients in a healthy-ageing formula, especially botanical extracts, need their own check, since some botanicals sold freely elsewhere are treated as medicines in Japan. See the Japan-made supplement OEM page, and compare with our NMN and coq10 guides if you are building a combined healthy-ageing formula.
Before you ask for a quotation
A factory can quote accurately once the source, the amount, the form and the packaging are fixed.
- Ergothioneine source (mushroom-derived or synthetic) and certificate of analysis
- Amount per serving and servings per pack
- Dosage form
- Companion ingredients and their amounts
- Packaging and stability requirements
- Countries you will sell in, and ergothioneine’s current status in each, including any novel food or maximum-intake rules
💬 Ready to design a Japan-made ergothioneine product? Send us the concept — source, amount, form and the countries you will sell in.
Frequently asked questions
1. Is there strong human evidence for ergothioneine?
Not yet. The evidence is still early: a small pilot study confirmed it is absorbed from mushrooms, and a 12-week trial of a mushroom extract found improvements in skin moisture and texture. Larger and longer trials are still needed.
2. Where does supplement ergothioneine come from?
It occurs naturally in mushrooms, and it is also produced synthetically for use as a defined novel food ingredient in the EU. Ask your supplier which source and specification they offer.
3. Is ergothioneine legal to sell in the EU?
Synthetic L-ergothioneine has EU novel food authorisation for food supplements, with a maximum intake of 30 mg a day for adults and 20 mg a day for children. That authorisation does not carry an approved health claim.
4. What has the skin trial on ergothioneine shown?
A 2024 trial of 77 women found that a 12-week daily ergothioneine-rich mushroom extract raised plasma ergothioneine and improved skin moisture and texture scores compared with placebo. It is one trial, not a settled body of evidence.
5. How is ergothioneine usually formulated?
As a hard capsule, tablet or powder stick, since it is stable and water-soluble at the milligram doses used in supplements.
Sources: “The bioavailability of ergothioneine from mushrooms (Agaricus bisporus) and the acute effects on antioxidant capacity and biomarkers of inflammation”, Preventive Medicine 2012;54(Suppl):S75-8 (PMID 22230474); “Effects of an ergothioneine-rich Pleurotus sp. on skin moisturizing functions and facial conditions: a randomized, double-blind, placebo-controlled trial”, Frontiers in Medicine 2024;11:1396783 (PMID 38887673); EFSA Scientific Opinion on the safety of synthetic L-ergothioneine as a novel food, EFSA Journal 2016 (doi 10.2903/j.efsa.2016.4629); Commission Implementing Regulation (EU) 2018/462 authorising an extension of use of L-ergothioneine as a novel food. Checked on 25 September 2026.